Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacque L Duncan

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
Human Molecular Genetics|April 24, 2016
A missense mutation in ASRGL1 is involved in causing autosomal recessive retinal degenerationPooja Biswas, Venkata Ramana Murthy Chavali, Giulia Agnello, et al.
Human Mutation|March 10, 2022
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A studyRobert B Hufnagel, Wendi Liang, Jacque L Duncan, et al.
Ophthalmology Science|January 15, 2025
Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) StudyDavid G Birch, Peiyao Cheng, Maureen G Maguire, et al.
Human Mutation|February 24, 2011
BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definitionCatherine Deveault, Gail Billingsley, Jacque L Duncan, et al.
Translational Vision Science & Technology|November 2, 2020
The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at BaselineDavid G Birch, Peiyao Cheng, Jacque L Duncan, et al.
Neurology|October 15, 2013
Quinacrine treatment trial for sporadic Creutzfeldt-Jakob diseaseMichael D Geschwind, Amy L Kuo, Katherine S Wong, et al.
Clinical & Experimental Ophthalmology|February 27, 2026
Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter StudyBela J Parekh, Joshua D Stein, Rebhi Abuzaitoun, et al.
American Journal of Ophthalmology|March 8, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100]Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|August 3, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|May 5, 2025
Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association StudyAjoy Vincent, Wendi Liang, Maureen G Maguire, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
Human Molecular Genetics|April 24, 2016
A missense mutation in ASRGL1 is involved in causing autosomal recessive retinal degenerationPooja Biswas, Venkata Ramana Murthy Chavali, Giulia Agnello, et al.
Human Mutation|March 10, 2022
Tissue-specific genotype-phenotype correlations among USH2A-related disorders in the RUSH2A studyRobert B Hufnagel, Wendi Liang, Jacque L Duncan, et al.
Ophthalmology Science|January 15, 2025
Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) StudyDavid G Birch, Peiyao Cheng, Maureen G Maguire, et al.
Human Mutation|February 24, 2011
BBS genotype-phenotype assessment of a multiethnic patient cohort calls for a revision of the disease definitionCatherine Deveault, Gail Billingsley, Jacque L Duncan, et al.
Translational Vision Science & Technology|November 2, 2020
The RUSH2A Study: Best-Corrected Visual Acuity, Full-Field Electroretinography Amplitudes, and Full-Field Stimulus Thresholds at BaselineDavid G Birch, Peiyao Cheng, Jacque L Duncan, et al.
Neurology|October 15, 2013
Quinacrine treatment trial for sporadic Creutzfeldt-Jakob diseaseMichael D Geschwind, Amy L Kuo, Katherine S Wong, et al.
Clinical & Experimental Ophthalmology|February 27, 2026
Decline of Visual Function and Risk of Legal Blindness With Age in RPGR-Associated Retinal Degeneration: A Multicenter StudyBela J Parekh, Joshua D Stein, Rebhi Abuzaitoun, et al.
American Journal of Ophthalmology|March 8, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity" [Am J Ophthalmol 2020;219:87-100]Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|August 3, 2025
Corrigendum to "Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity." Am J Ophthalmol. 2020; 219:87-100Jacque L Duncan, Wendi Liang, Maureen G Maguire, et al.
American Journal of Ophthalmology|May 5, 2025
Natural History of Microperimetry and Optical Coherence Tomography in USH2A-Retinopathy: A Structure-Function Association StudyAjoy Vincent, Wendi Liang, Maureen G Maguire, et al.
Pageof 17